Redcare Pharmacy NV
XETRA:RDC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
98
170.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Redcare Pharmacy NV
Redcare Pharmacy NV
Cost of Revenue
Redcare Pharmacy NV
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Redcare Pharmacy NV
XETRA:RDC
|
Cost of Revenue
-€1.7B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Redcare Pharmacy NV
Glance View
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 1,847 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
See Also
What is Redcare Pharmacy NV's Cost of Revenue?
Cost of Revenue
-1.7B
EUR
Based on the financial report for Sep 30, 2024, Redcare Pharmacy NV's Cost of Revenue amounts to -1.7B EUR.
What is Redcare Pharmacy NV's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-26%
Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Redcare Pharmacy NV have been -30% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
